ADA: Tirzepatide Reduces Apnea-Hypopnea Index in Moderate-to-Severe OSA
Two randomized controlled trials show reduction in AHI; significant improvements seen in all secondary end points
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.